Xortx welcomes new member to the board of directors and appoints chair

Calgary, alberta, june 06, 2022 (globe newswire) -- xortx therapeutics inc. ("xortx" or the “company”) (nasdaq: xrtx | tsxv: xrtx | frankfurt: anu), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to welcome and appoint mr. anthony giovinazzo to the board of directors and as chair of the board.

XRTX Ratings Summary

XRTX Quant Ranking